Back to search
FDAFDA · Food and drugs·Recall number D-0094-2024

Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11

Published November 15, 2023 · Recall initiated: October 20, 2023

Summary

FDA records drug Class III recall D-0094-2024, published November 15, 2023 and initiated October 20, 2023. Recalling firm: Zyla Life Sciences US Inc.; Status: Ongoing; Reported quantity: 3,792 bottles; Lot: Lot 22W02, Exp 01/31/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-potent Drug: Lower potency than labeled.

What to do

Voluntary: Firm initiated · Letter

Get an email if OXAYDO has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
OXAYDO
Manufacturer
Zyla Life Sciences US Inc.
Distributor
Nationwide
UPC
0369344213119
Lot
Lot 22W02, Exp 01/31/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11 recalled?

Yes. FDA published recall D-0094-2024 on November 15, 2023. Reported hazard: Sub-potent Drug: Lower potency than labeled.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OXAYDO. UPC: 0369344213119.